The lives of three men were honored recently through a $1.5 million gift to establish the Stewart, Hughes, and Wendt ALS Research Endowment. The endowment supports amyotrophic lateral sclerosis (ALS) research at Duke and acknowledges D. Loy Stewart, Larry V. Hughes, and George C. Wendt, three individuals who died of the disease.
Duke Children’s Hospital once again ranked among the top 50 children’s medical centers nationally and retained its position at No. 1 in North Carolina, according to this year’s annual list from U.S. News & World Report.
A family foundation established by the late Dudley Rauch, AB’63, has pledged $30 million to establish an endowment for need-based financial aid for medical students in the Duke University School of Medicine.
From frontline health workers helping patients, to staff and faculty members figuring out everything from surveillance testing to remote teaching, everyone at Duke responded to the COVID-19 pandemic in their own way.
A Parent’s Love and Tenacity Leads to Duke Eye Center, and an Appeal to Innovate
The Duke Endowment of Charlotte, N.C., is supporting Duke University’s efforts to expand its faculty in computation, materials science and the resilience of the body and brain by completing the second phase of a $100 million investment.
A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections — including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic. The findings were published in the journal Nature.
Fred Sanfilippo, MD, PhD, of Atlanta, is grateful for the medical education he received at Duke, as well as the life-saving care given to his wife. The couple established a trust fund and scholarship to benefit MD/PhD students.
Twin 9-year-old girls at Duke Health became the first in the United States to participate in a Pfizer and BioNTech Phase 1 study to evaluate safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in preventing COVID-19 among healthy children below the age of 12.